Pliant Therapeutics, Inc.

PLRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001746473

SEC filings (opens in a new tab)

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Pliant Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of PLRX: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	135	1	144	+10
Shares	65.2M	65.0K	63.9M	−1.19M (−1.8%)
Value	$971.3M	$968.9K	$687.2M	−$283.1M (−29.2%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to PLRX in Q2 2024
Institution	Shares	Value	% of portfolio
Checkpoint Capital L.P.	232,200	$2.50M	1.50%
Trexquant Investment LP	158,700	$1.71M	0.03%
Rice Hall James & Associates, LLC	127,634	$1.37M	0.08%
Exome Asset Management LLC	124,000	$1.33M	1.19%
Squarepoint Ops LLC	80,475	$865.1K	0.00%
UBS Oconnor LLC	77,000	$827.8K	0.02%
Hennion & Walsh Asset Management, Inc.	68,289	$734.1K	0.04%
PDT Partners, LLC	63,352	$681.0K	0.06%
Verition Fund Management LLC	56,501	$607.4K	0.00%
Acuta Capital Partners, LLC	46,200	$496.6K	0.42%
Prelude Capital Management, LLC	38,200	$410.6K	0.03%
Balyasny Asset Management LLC	31,910	$343.0K	0.00%
Corebridge Financial, Inc.	30,655	$329.5K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	29,286	$314.8K	0.00%
Dynamic Technology Lab Private Ltd	17,487	$188.0K	0.02%
State Board of Administration of Florida Retirement System	16,180	$173.9K	0.00%
Graham Capital Management, L.P.	15,022	$161.5K	0.01%
Atria Wealth Solutions, Inc.	11,715	$125.9K	0.00%
Deerfield Management Company, L.P. (Series C)	11,678	$125.5K	0.00%
D. E. Shaw & Co., Inc.	10,679	$114.8K	0.00%
ADAR1 Capital Management, LLC	10,000	$107.5K	0.02%
Clear Street Markets LLC	5,532	$59.0K	0.02%
Mirae Asset Global Investments Co., Ltd.	1,801	$19.2K	0.00%
Lindbrook Capital, LLC	137	$1.47K	0.00%
Quarry LP	104	$1.12K	0.00%
Smartleaf Asset Management LLC	98	$1.04K	0.00%
Global Retirement Partners, LLC	4	$43	0.00%
Capital Advisors, Ltd. LLC	13	$0	0.00%

Sold out (18)

Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of PLRX in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Ameriprise Financial Inc	371,126	$5.53M
Cutter Capital Management, LP	194,119	$2.89M
Silverarc Capital Management, LLC	183,392	$2.73M
Marshall Wace, LLP	130,935	$1.95M
Fred Alger Management, LLC	97,082	$1.45M
Atom Investors LP	58,064	$865.2K
HighVista Strategies LLC	34,039	$507.2K
American International Group, Inc.	28,165	$419.7K
Rathbone Brothers plc	11,700	$174.3K
HSBC Holdings PLC	10,507	$156.5K
Metropolitan Life Insurance Co	3,049	$45.4K
Signaturefd, LLC	417	$6.21K
Truvestments Capital LLC	184	$2.74K
Allworth Financial LP	157	$2.34K
Sofos Investments, Inc.	19	$290
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	11	$163
Mine & Arao Wealth Creation & Management, LLC.	2	$30
CWM, LLC	1	$0

Not filed for Q2 2024 yet (1)

Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLRX in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	65,025	$968.9K